Myelodysplastic syndrome with isolated deletion of chromosome 20q: an indolent disease with minimal morphological dysplasia and frequent thrombocytopenic presentation

被引:43
作者
Gupta, Raavi
Soupir, Chad P.
Johari, Vandita
Hasserjian, Robert P.
机构
[1] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[2] Columbia Univ, Med Ctr, Dept Pathol, New York, NY USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Baystate Med Ctr, Springfield, MA USA
[5] Tufts Univ, Sch Med, Springfield, MA 01199 USA
关键词
myelodysplastic syndromes; thrombocytopenia; cytogenetics; histopathology; idiopathic thrombocytopenic purpura;
D O I
10.1111/j.1365-2141.2007.06776.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study analysed the clinicopathological features of nine myelodysplastic syndrome (MDS) patients in which del(20q) was the sole cytogenetic abnormality and a control group of 17 adult patients with idiopathic thrombocytopenic purpura (ITP). Seven of nine del(20q) patients were thrombocytopenic and six of nine were mildly anaemic at presentation. There was no significant morphological dysplasia identified in the del(20q) group as compared with the ITP group. These results indicate that MDS with del(20q) commonly presents with thrombocytopenia and has minimal morphological dysplasia. Cytogenetic analysis on adult patients undergoing bone marrow sampling for thrombocytopenia may help avoid misdiagnosis of MDS with del(20q) as ITP.
引用
收藏
页码:265 / 268
页数:4
相关论文
共 9 条
  • [1] Brunning RD, 2001, World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, P61
  • [2] Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology
    George, JN
    Woolf, SH
    Raskob, GE
    Wasser, JS
    Aledort, LM
    Ballem, PJ
    Blanchette, VS
    Bussel, JB
    Cines, DB
    Kelton, JG
    Lichtin, AE
    McMillan, R
    Okerbloom, JA
    Regan, DH
    Warrier, I
    [J]. BLOOD, 1996, 88 (01) : 3 - 40
  • [3] Idiopathic thrombocytopenic purpura in adults: current issues for pathogenesis, diagnosis and management
    George, JN
    [J]. HEMATOLOGY JOURNAL, 2004, 5 : S12 - S14
  • [4] International scoring system for evaluating prognosis in myelodysplastic syndromes
    Greenberg, P
    Cox, C
    LeBeau, MM
    Fenaux, P
    Morel, P
    Sanz, G
    Sanz, M
    Vallespi, T
    Hamblin, T
    Oscier, D
    Ohyashiki, K
    Toyama, K
    Aul, C
    Mufti, G
    Bennett, J
    [J]. BLOOD, 1997, 89 (06) : 2079 - 2088
  • [5] Kurtin PJ, 1996, AM J CLIN PATHOL, V106, P680
  • [6] Risk factor analysis in myelodysplastic syndrome patients with del(20q): prognosis revisited
    Liu, Yi-Chang
    Ito, Yoshikazu
    Hsiao, Hui-Hua
    Sashida, Goro
    Kodama, Atsushi
    Ohyashiki, Junko H.
    Ohyashiki, Kazuma
    [J]. CANCER GENETICS AND CYTOGENETICS, 2006, 171 (01) : 9 - 16
  • [7] REFRACTORY THROMBOCYTOPENIA - A MYELODYSPLASTIC SYNDROME THAT MAY MIMIC IMMUNE THROMBOCYTOPENIC PURPURA
    MENKE, DM
    COLONOTERO, G
    COCKERILL, KJ
    JENKINS, RB
    NOEL, P
    PIERRE, RV
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1992, 98 (05) : 502 - 510
  • [8] Clinico-hematologic features of myelodysplastic syndrome presenting as isolated thrombocytopenia: An entity with a relatively favorable prognosis
    Sashida, G
    Takaku, TI
    Shoji, N
    Nishimaki, J
    Ito, Y
    Miyazawa, K
    Kimura, Y
    Ohyashiki, JH
    Ohyashiki, K
    [J]. LEUKEMIA & LYMPHOMA, 2003, 44 (04) : 653 - 658
  • [9] Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia?
    Steensma, DP
    Dewald, GW
    Hodnefield, JM
    Tefferi, A
    Hanson, CA
    [J]. LEUKEMIA RESEARCH, 2003, 27 (03) : 235 - 242